Delivery Order SPE2DB20D3103-SPE2DB24FP8E2

Award Date 8/7/24
Potential Completion Date 8/8/24
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,937.74, is for the delivery of Diltiazem 12HR ER 60 mg capsules and has a completion date of March 19, 2024. The contract is a firm fixed price agreement and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract, valued at $1,492.39, is for the delivery of Diltiazem 12HR ER 60 MG capsules in 100-count packages. This is a firm fixed price delivery order contract with no set-aside designation. Amerisourcebergen Drug Corp also holds an Indefinite...
This is a federal contract award issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,641.39 Firm Fixed Price delivery order covers the supply of 100 units of Diltiazem 12HR ER 60 MG capsules, a cardiovascular medication. The award is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office Division. The $1,389.55 firm-fixed-price delivery order is for the supply of 4,565,837,162 units of the prescription drug Diltiazem 12HR ER 60 mg Capsules. The contract has an ultimate completion date of September 18, 2024 and does not utilize any set-aside designations. Amerisourcebergen is a major pharmaceutical distributor that holds...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Diltiazem 12HR ER 120 MG Capsules. The $5,300.65 Firm Fixed Price contract was issued by the Defense Logistics Agency (DLA) as a Delivery Order against the company's existing Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. This IDC serves as the primary vehicle for Amerisourcebergen to provide a broad range of pharmaceutical products and medical supplies to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,526.04 Firm Fixed Price Delivery Order contract is for the supply of Diltiazem 12HR ER 90 mg capsules, a cardiovascular medication, to support military treatment facilities and federal healthcare programs. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $2,669.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract covers the delivery of diltiazem 12-hour extended-release 60 mg capsules for the DLA Troop Support Medical program. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive range of...
This is a federal contract award made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,476.06 firm fixed-price delivery order is for the supply of DILTIAZEM 12HR ER 60 MG CAP 100S, a cardiovascular medication. The award is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,553.01 firm-fixed-price contract is for the delivery of 100 capsules of Diltiazem 12-hour extended-release 60 mg, a cardiovascular medication. The award is not associated with a set-aside program. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of Diltiazem 12HR ER 120 mg capsules in quantities of 100 to the Defense Logistics Agency (DLA). The contract has a total ceiling value of $3,217.23 and an ultimate completion date of January 29, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies. Amerisourcebergen is a subsidiary of...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB24FP8E2
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,300.24 firm fixed-price delivery order is for the supply of Diltiazem 12HR ER 120 mg capsules. The contract has an ultimate completion date of August 8, 2024.

Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as the primary vehicle for providing a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation through May 2024, covering similar medical commodities. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.

The contract award reviewed was not designated with any set-aside requirements, indicating open competition.

Generated 2/27/25, 11:56 AM